11-74457366-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005472.5(KCNE3):​c.198T>C​(p.Phe66Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.12 in 1,614,094 control chromosomes in the GnomAD database, including 12,760 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1316 hom., cov: 32)
Exomes 𝑓: 0.12 ( 11444 hom. )

Consequence

KCNE3
NM_005472.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.433

Publications

26 publications found
Variant links:
Genes affected
KCNE3 (HGNC:6243): (potassium voltage-gated channel subfamily E regulatory subunit 3) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, isk-related subfamily. This member is a type I membrane protein, and a beta subunit that assembles with a potassium channel alpha-subunit to modulate the gating kinetics and enhance stability of the multimeric complex. This gene is prominently expressed in the kidney. A missense mutation in this gene is associated with hypokalemic periodic paralysis. [provided by RefSeq, Jul 2008]
KCNE3 Gene-Disease associations (from GenCC):
  • Brugada syndrome 6
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • Brugada syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 11-74457366-A-G is Benign according to our data. Variant chr11-74457366-A-G is described in ClinVar as Benign. ClinVar VariationId is 259778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.433 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.197 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNE3NM_005472.5 linkc.198T>C p.Phe66Phe synonymous_variant Exon 3 of 3 ENST00000310128.9 NP_005463.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNE3ENST00000310128.9 linkc.198T>C p.Phe66Phe synonymous_variant Exon 3 of 3 1 NM_005472.5 ENSP00000310557.4

Frequencies

GnomAD3 genomes
AF:
0.125
AC:
18972
AN:
152132
Hom.:
1316
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.123
Gnomad AMI
AF:
0.171
Gnomad AMR
AF:
0.0907
Gnomad ASJ
AF:
0.108
Gnomad EAS
AF:
0.145
Gnomad SAS
AF:
0.208
Gnomad FIN
AF:
0.228
Gnomad MID
AF:
0.142
Gnomad NFE
AF:
0.111
Gnomad OTH
AF:
0.103
GnomAD2 exomes
AF:
0.132
AC:
33053
AN:
251278
AF XY:
0.136
show subpopulations
Gnomad AFR exome
AF:
0.129
Gnomad AMR exome
AF:
0.0873
Gnomad ASJ exome
AF:
0.111
Gnomad EAS exome
AF:
0.130
Gnomad FIN exome
AF:
0.219
Gnomad NFE exome
AF:
0.110
Gnomad OTH exome
AF:
0.126
GnomAD4 exome
AF:
0.120
AC:
175488
AN:
1461844
Hom.:
11444
Cov.:
32
AF XY:
0.123
AC XY:
89420
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.126
AC:
4204
AN:
33478
American (AMR)
AF:
0.0887
AC:
3965
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.107
AC:
2806
AN:
26132
East Asian (EAS)
AF:
0.147
AC:
5818
AN:
39698
South Asian (SAS)
AF:
0.208
AC:
17913
AN:
86258
European-Finnish (FIN)
AF:
0.218
AC:
11654
AN:
53416
Middle Eastern (MID)
AF:
0.121
AC:
699
AN:
5768
European-Non Finnish (NFE)
AF:
0.109
AC:
120899
AN:
1111978
Other (OTH)
AF:
0.125
AC:
7530
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
8998
17995
26993
35990
44988
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4498
8996
13494
17992
22490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.125
AC:
18976
AN:
152250
Hom.:
1316
Cov.:
32
AF XY:
0.132
AC XY:
9789
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.123
AC:
5111
AN:
41558
American (AMR)
AF:
0.0903
AC:
1383
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.108
AC:
375
AN:
3472
East Asian (EAS)
AF:
0.144
AC:
747
AN:
5186
South Asian (SAS)
AF:
0.208
AC:
1004
AN:
4824
European-Finnish (FIN)
AF:
0.228
AC:
2409
AN:
10586
Middle Eastern (MID)
AF:
0.143
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
0.111
AC:
7533
AN:
68000
Other (OTH)
AF:
0.102
AC:
216
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
868
1735
2603
3470
4338
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
224
448
672
896
1120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.112
Hom.:
4926
Bravo
AF:
0.111
Asia WGS
AF:
0.187
AC:
653
AN:
3478
EpiCase
AF:
0.106
EpiControl
AF:
0.106

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 16374062) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Brugada syndrome 6 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
May 14, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
11
DANN
Benign
0.61
PhyloP100
0.43
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2270676; hg19: chr11-74168411; COSMIC: COSV59552214; COSMIC: COSV59552214; API